相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer
Jamshid Gholizadeh Navashenaq et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
Parvin Zamani et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine
Zahra Gholizadeh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity
Alessandra Ventura et al.
CANCER RESEARCH (2018)
Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
Sara Nikoofal-Sahlabadi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
Yoo Jin Choi et al.
PLOS ONE (2018)
Current status and future directions of cancer immunotherapy
Hongming Zhang et al.
JOURNAL OF CANCER (2018)
Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model
Afshin Namdar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer
Nastaran Barati et al.
IMMUNOLOGY LETTERS (2017)
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma
Keitaro Fukuda et al.
MELANOMA RESEARCH (2017)
Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies
Amin Reza Nikpoor et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine
Sudeep Kumar et al.
VACCINE (2017)
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
Arata Takeuchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting inhibition of Foxp3 by a CD28 2′-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy
Teresa Lozano et al.
BIOMATERIALS (2016)
Ly6C+ monocyte efferocytosis and cross-presentation of cell-associated antigens
S. R. Larson et al.
CELL DEATH AND DIFFERENTIATION (2016)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer
Sheida Shariat et al.
CANCER LETTERS (2014)
Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN
Mercedeh Mansourian et al.
IMMUNOLOGY LETTERS (2014)
Microbial Activation of Gut Dendritic Cells and the Control of Mucosal Immunity
Jennifer L. Owen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Platelets Present Antigen in the Context of MHC Class I
Lesley M. Chapman et al.
JOURNAL OF IMMUNOLOGY (2012)
Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles
Seyed Amir Jalali et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
IFN regulatory factor-1 negatively regulates CD4+CD25+ regulatory T cell differentiation by repressing Foxp3 expression
Alessandra Fragale et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell Vaccines
Shinjiro Yamaguchi et al.
CANCER (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Platelets: signaling cells in the immune continuum
AS Weyrich et al.
TRENDS IN IMMUNOLOGY (2004)
Cutting edge:: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo
JCE Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets
NC Kaneider et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2003)
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma
AC Peterson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
ML Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity
B Ludewig et al.
VACCINE (2000)
分享论文
